Good Health Medicine

Main Menu

  • Home
  • Health medicine
  • Dietary supplements
  • Dietary nutrition
  • Alternative medication
  • Medicine price

Good Health Medicine

Header Banner

Good Health Medicine

  • Home
  • Health medicine
  • Dietary supplements
  • Dietary nutrition
  • Alternative medication
  • Medicine price
Dietary supplements
Home›Dietary supplements›The future of dietary supplements discussed at the RSQ of the CPHA

The future of dietary supplements discussed at the RSQ of the CPHA

By Rebecca C. Myers
September 20, 2021
0
0

Washington DC—The Consumer Healthcare Products Association (CHPA) held its 2021 Regulatory, Science and Quality (RSQ) conference virtually last week.

CPHA said in a press release that the event featured record attendance from the U.S. Food and Drug Administration (FDA), including Acting Commissioner Janet Woodcock, MD, and Acting Director of the Center for Food Safety and Applied Nutrition (CFSAN) Office of Dietary Supplement Programs (ODSP), Cara Welch, Ph.D.

Some highlights, according to the press release:

  • Modernize DHEA. Dr Woodcock highlighted the need to update the Dietary Supplement Health and Education Act, 1994 (DSHEA). “The industry is not in the same place it was 27 years ago when the DSHEA was adopted,” she said. “We all know that. We have people all over the United States taking multiple dietary supplements, and our job is to make sure they don’t get harmed by them. That these dangerous or illegal products don’t go in. in the marketplace and holding companies accountable if they do not comply with the requirements of the law, but our tools to do so are quite limited.
  • FDA-industry collaboration. Emphasizing the importance of industry collaboration to strengthen the DSHEA framework, Dr Woodcock said, “I think we need to mutually and in collaboration with industry assess the current regulatory framework to ensure that the FDA has the tools to keep bad market players out, to keep industry reputation issues good and strong, and to protect patients and consumers as well. “
  • Mandatory product list. Dr Cara Welch discussed the DSHEA and the role that mandatory product listing can play in enabling the FDA to better manage its resources and educate retailers and consumers about marketed products. “The conversation between patient and health care provider can really be informed by a list of products,” said Dr. Welch. “If someone can literally put up a list and tell their doctor, ‘this is the product I’m taking,’ they can see it. What are the levels of these ingredients? How might this product affect what else my patient is taking? “
    During a panel discussion, Liz Richardson, director of the healthcare products project at Pew Charitable Trusts, noted overwhelming bipartisan support for the list of products, with 97% of Democrats and 93% of Republicans supporting the policy. .
  • CBD Regulation. Dr Woodcock discussed the FDA’s interagency work on cannabidiol (CBD) regulatory policy, stating :, the safety and quality of products containing CBD. To this end, we remain unwavering in our efforts to obtain research, data and other contributions in public health and safety to inform our approach and address consumer access in a way that protects public health. and maintains incentives for the development of cannabis-based medicines through established regulatory channels. “

Other strengths of food supplements, according to the press release:

  • Discussion of the standards underlying the notification of novel food ingredients (NDIN) and pathways generally recognized as safe (GRAS);
  • Overview of the regulatory, scientific and legislative landscape of CBD;
  • Discussion on retailers’ support for harmonizing quality programs to protect consumers when purchasing products;
  • Insight into the growing use and future of probiotics.

Registration to watch all on-demand content will remain open until October 10.


Previous articleGIG’s partnerships with food manufacturers highlighted at Expo East
Next articleIn Memoriam: Marlene Lacy, A Natural Foods Way of Life, 1936-2021


Source link

Related posts:

  1. The dietary supplement market is expected to grow massively in nearly
  2. The market for nutritional food supplements will experience significant growth
  3. Global Over-the-Counter Drugs and Dietary Supplements Market 2021 Driving Factors – Pfizer Inc., Novartis International AG, Roche Holding AG, Merck & Co., Inc.
  4. 9 best supplements for arthritis of 2021
Tagsdietary supplementsunited states
  • Alternative medication
  • Dietary nutrition
  • Dietary supplements
  • Health medicine
  • Medicine price
  • Flavo Trim Review – Is Clarity Nutrition FlavoTrim Weight Loss Supplement Legit or Fraudulent?
  • Are Performance Lab supplements safe? Read shocking user report
  • Online Loans Market Size and Forecast
  • Thailand provides free cannabis plants for home cultivation | Health, Medicine and Fitness
  • To solve the nutrition crisis, Biden must first look inward – New York Daily News
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • August 2020
  • May 2020
  • March 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • March 2018
  • February 2018
  • January 2018
  • October 2017
  • August 2017
  • August 2016
  • May 2016
  • October 2015
  • August 2015
  • March 2014
  • December 2013
  • September 2012
  • October 2011
  • September 2011
  • July 2011
  • June 2011
  • April 2011
  • March 2011
  • March 2010
  • September 2007
  • Privacy Policy
  • Terms and Conditions